Contribution of arginase activation to vascular dysfunction in cigarette smoking

Atherosclerosis

Volumn 231, Issue 1, 2013, Pages 91-94

  Sikka, Gautam ^a   Pandey, Deepesh ^a   Bhuniya, Anil K ^a   Steppan, Jochen ^a   Armstrong, Dinani ^a   Santhanam, Lakshmi ^a   Nyhan, Daniel ^a   Berkowitz, Dan E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arginase; Cholinergic response; Cigarette smoking; Endothelial dysfunction; Nitric oxide; ROS; Second hand smoke; Superoxide; Vascular stiffness; Vasodilation

Indexed keywords

ARGINASE; ARGINASE 2; CIGARETTE SMOKE; FLUORESCENT DYE; HYDROETHIDINE; HYDROLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL STIFFNESS; ARTICLE; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; ENDOTHELIAL DEPENDENT VASODILATION; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; HOME; MALE; MOUSE; NONHUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; PULSE WAVE; SMOKING; THORACIC AORTA; UPREGULATION; UREA CYCLE; VASCULAR DISEASE;

ARGINASE; CHOLINERGIC RESPONSE; CIGARETTE SMOKING; ENDOTHELIAL DYSFUNCTION; NITRIC OXIDE; ROS; SECOND HAND SMOKE; SUPEROXIDE; VASCULAR STIFFNESS; VASODILATION;

ANIMALS; AORTA; ARGINASE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; TOBACCO SMOKE POLLUTION; VASCULAR STIFFNESS;

EID: 84885416017     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.08.026     Document Type: Article

References (37)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
2. Rangasamy T., Cho C.Y., Thimmulappa R.K., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. JClin Investig 2004, 114:1248-1259.
3. Shah R.S., Cole J.W. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 2010, 8:917-932.
4. Roquer J., Segura T., Serena J., Castillo J. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis 2009, 27(Suppl.1):25-37.
5. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. JAm Coll Cardiol 2004, 43:1731-1737.
6. Csordas A., Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke, nature reviews. Cardiology 2013, 10:219-230.
7. Su Y., Han W., Giraldo C., De Li Y., Block E.R. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998, 19:819-825.
8. Smoking and Health: New research. Book edited by Owing JH, c. b. W. e. a.
9. Wagner L., Laczy B., Tamasko M., et al. Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C. Endothel J Endothel Cell Res 2007, 14:245-255.
10. Barua R.S., Ambrose J.A., Eales-Reynolds L.J., DeVoe M.C., Zervas J.G., Saha D.C. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001, 104:1905-1910.
11. Steppan J., Ryoo S., Schuleri K.H., et al. Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S Am 2006, 103:4759-4764.
12. Ryoo S., Gupta G., Benjo A., et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 2008, 102:923-932.
13. Ryoo S., Berkowitz D.E., Lim H.K. Endothelial arginase II and atherosclerosis. Korean J Anesthesiol 2011, 61:3-11.
14. Haraguchi Y., Takiguchi M., Amaya Y., Kawamoto S., Matsuda I., Mori M. Molecular cloning and nucleotide sequence of cDNA for human liver arginase. Proc Natl Acad Sci U S Am 1987, 84:412-415.
15. Chang C.I., Liao J.C., Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol 1998, 274:H342-H348.
16. Sonoki T., Nagasaki A., Gotoh T., et al. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues invivo by lipopolysaccharide. JBiol Chem 1997, 272:3689-3693.
17. Ryoo S., Lemmon C.A., Soucy K.G., et al. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res 2006, 99:951-960.
18. Koga T., Koshiyama Y., Gotoh T., et al. Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. Exp Eye Res 2002, 75:659-667.
19. Louis C.A., Reichner J.S., Henry W.L., et al. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol 1998, 274:R775-R782.
20. Modolell M., Corraliza I.M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995, 25:1101-1104.
21. Morris S.M., Kepka-Lenhart D., Chen L.C. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol 1998, 275:E740-E747.
22. Ignarro L.J., Buga G.M., Wei L.H., Bauer P.M., Wu G., del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S Am 2001, 98:4202-4208.
23. Sikka G., Yang R., Reid S., et al. Leptin is essential in maintaining normal vascular compliance independent of body weight. Int J Obes (Lond) 2010, 34:203-206.
24. Yang R., Sikka G., Larson J., et al. Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 2011, 300:H1467-H1476.
25. van der Zee R., Murohara T., Luo Z., et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997, 95:1030-1037.
26. Sikka G., Miller K.L., Steppan J., et al. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Exp Gerontol 2013, 48:128-135.
27. Kim J.H., Bugaj L.J., Oh Y.J., et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. JAppl Physiol 2009, 107:1249-1257.
28. Siasos G., Tousoulis D., Vlachopoulos C., et al. The impact of oral l-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. Am J Hypertens 2009, 22:586-592.
29. Siasos G., Tousoulis D., Vlachopoulos C., et al. Short-term treatment with l-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals. Int J Cardiol 2008, 126:394-399.
30. Bivalacqua T.J., Sussan T.E., Gebska M.A., et al. Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. Journal Urol 2009, 181:899-906.
31. Vanhoutte P.M., Shimokawa H., Tang E.H., Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009, 196:193-222.
32. Maarsingh H., Zaagsma J., Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 2009, 158:652-664.
33. Dayal S., Lentz S.R. ADMA and hyperhomocysteinemia. Vasc Med 2005, 10(Suppl.1):S27-S33.
34. Krzyzanowska K., Mittermayer F., Krugluger W., et al. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis 2006, 189:236-240.
35. Stuhlinger M.C., Stanger O. Asymmetric dimethyl-l-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. Curr Drug Metab 2005, 6:3-14.
36. Ryoo S., Bhunia A., Chang F., Shoukas A., Berkowitz D.E., Romer L.H. OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 2011, 214:279-287.
37. Boger R.H., Sydow K., Borlak J., et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement ofS-adenosylmethionine-dependent methyltransferases. Circ Res 2000, 87:99-105.